Peptide density targets and impedes triple negative breast cancer metastasis

Area of Science:

• Oncology
• Nanotechnology
• Molecular Biology

Background:

• The C-X-C chemokine receptor type 4 (CXCR4) pathway is crucial in regulating cancer metastasis.
• Current CXCR4-targeting therapies rely on single molecule interactions or gene silencing, with limitations.
• CXCR4's localization in lipid rafts and dimerization suggests ligand density influences its targeting and signaling.

Purpose of the Study:

• To investigate liposomes functionalized with a CXCR4-binding peptide (DV1) as a three-dimensional molecular array for targeting triple-negative breast cancer (TNBC).
• To determine the optimal peptide density on liposomes for maximum binding and uptake by TNBC cells.
• To evaluate the effect of this targeted delivery on cancer cell migration and metastasis.

Main Methods:

• Development of liposomes presenting the DV1 peptide at varying densities (9k to 74k molecules μm⁻²).
• In vitro assessment of liposome binding and uptake by TNBC cells at different peptide densities.
• Evaluation of the impact of optimal liposome density on TNBC cell migration and in vivo metastasis inhibition.
• Analysis of peptide density-dependent gene regulation in response to liposome treatment.

Main Results:

• TNBC cells showed maximal binding and uptake of DV1-functionalized liposomes (L-DV1) at a specific peptide density.
• This optimal density significantly reduced TNBC cell migration in vitro.
• Treatment with L-DV1 at the optimal density inhibited metastasis from a primary tumor for 27 days.
• Peptide density-dependent gene regulation was identified as the mechanism underlying metastasis inhibition.

Conclusions:

• Liposomes presenting CXCR4-binding peptides in a controlled, high-density array offer a novel strategy for targeting TNBC.
• Optimizing ligand density on nanocarriers can enhance cellular targeting and therapeutic efficacy.
• Modulating cell membrane receptor expression through targeted delivery presents a promising approach for cancer therapy.